We are live on
!
Find out more
GCA
Greenwood Capital Associates Portfolio holdings
AUM
$1.02B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+17.41%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$595M
AUM Growth
+$80.2M
(+16%)
Cap. Flow
+$9.15M
Cap. Flow
% of AUM
1.54%
Top 10 Holdings %
Top 10 Hldgs %
24.78%
Holding
215
New
32
Increased
102
Reduced
64
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$7.87M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$6.57M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.28M |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$4.61M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$4.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$5.61M |
| 2 |
iShares MSCI Germany ETF
EWG
|
+$4.71M |
| 3 |
iShares Russell 3000 ETF
IWV
|
+$4.55M |
| 4 |
Akamai
AKAM
|
+$4.4M |
| 5 |
Qualcomm
QCOM
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.08% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 9.45% |
| 4 | Industrials | 8.89% |
| 5 | Communication Services | 7.11% |
Similar funds
SVCP
EFM
CC
MSA
MAM
IAS
WA
GA
Greenwood Capital Associates's Q4 2020 Portfolio in Review
As of Q4 2020, Greenwood Capital Associates held 215 positions worth $595M, up 16% from $515M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Greenwood Capital Associates's Q4 2020 filing shows 32 new, 102 increased, 64 reduced and 13 closed positions. Its largest new stake was Vertex Pharmaceuticals: 19,829 shares worth $4.69M. The largest sale was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $5.61M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Greenwood Capital Associates's largest Q4 2020 buy was Vertex Pharmaceuticals: 19,829 shares worth $4.69M.
- Greenwood Capital Associates added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $7.87M increase.
- Greenwood Capital Associates's biggest Q4 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $5.61M.
- Greenwood Capital Associates fully exited Akamai in Q4 2020, selling an estimated $4.4M.
- Greenwood Capital Associates's ten largest holdings make up 25% of its $595M portfolio in Q4 2020.
- Greenwood Capital Associates opened 32 new positions and closed 13 in Q4 2020.
- Greenwood Capital Associates's portfolio value rose 16% quarter-over-quarter to $595M.
Based on Greenwood Capital Associates's 13F filing for Q4 2020, filed 9 Feb 2021.